Patents by Inventor Eva Erlandsson

Eva Erlandsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONJUGATES BETWEEN A VARIANT STAPHYLOCOCCAL ENTEROTOXIN E SUPERANTIGEN AND A TARGETING ANTIBODY THAT BINDS TO A CANCER-ASSOCIATED CELL SURFACE STRUCTURE
    Publication number: 20100111978
    Abstract: The present invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. More particularly, the bacterial superantigen has been modified to decrease seroreactivity with retained superantigen activity.
    Type: Application
    Filed: September 28, 2009
    Publication date: May 6, 2010
    Applicant: ACTIVE BIOTECH AB
    Inventors: GORAN FORSBERG, EVA ERLANDSSON, PER ANTONSSON, BJORN WALSE
  • Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
    Patent number: 7615225
    Abstract: The present invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. More particularly, the bacterial superantigen has been modified to decrease seroreactivity with retained superantigen activity.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: November 10, 2009
    Assignee: Active Biotech AB
    Inventors: Goran Forsberg, Eva Erlandsson, Per Antonsson, Bjorn Walse
  • Novel engineered superantigen for human therapy
    Publication number: 20070082001
    Abstract: The present invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. More particularly, the bacterial superantigen has been modified to decrease seroreactivity with retained superantigen activity.
    Type: Application
    Filed: November 21, 2006
    Publication date: April 12, 2007
    Applicant: ACTIVE BIOTECH AB
    Inventors: Goran Forsberg, Eva Erlandsson, Per Antonsson, Bjorn Walse
  • Engineered superantigen for human therapy
    Patent number: 7125554
    Abstract: The present invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. More particularly, the bacterial superantigen has been modified to decrease seroreactivity with retained superantigen activity.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: October 24, 2006
    Assignee: Active Biotech AB
    Inventors: Goran Forsberg, Eva Erlandsson, Per Antonsson, Bjorn Walse
  • Novel engineered superantigen for human therapy
    Publication number: 20030039655
    Abstract: The present invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. More particularly, the bacterial superantigen has been modified to decrease seroreactivity with retained superantigen activity.
    Type: Application
    Filed: July 6, 2001
    Publication date: February 27, 2003
    Inventors: Goran Forsberg, Eva Erlandsson, Per Antonsson, Bjorn Walse